Filing Flows › Comparisons › CBDY vs NPHC
Target Group vs Nutra Pharma: CBDY and NPHC compared
Target Group is the larger company: $1.4M of revenue in its latest quarter (Q2 2026) against $34K for Nutra Pharma (Q2 2026). Target Group is growing faster (+11% against -59% a year earlier).
Where the money goes: CBDY and NPHC
Target Group (CBDY) · Q2 2026
Target Group, Q2 2026: revenue $1.4M (+11% year over year), operating margin -17.4%, net loss $240K, operating cash flow −$223K. The chart follows the revenue to costs, profit and cash.
Nutra Pharma (NPHC) · Q2 2026
Nutra Pharma, Q2 2026: revenue $34K (-59% year over year), net loss $3.9M, operating cash flow −$251K. The chart follows the revenue to costs, profit and cash.
| Target Group (CBDY) | Nutra Pharma (NPHC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.4M | $34K |
| Revenue growth, Y/Y | +11% | -59% |
| Operating margin | -17.4% | n/m |
| Net earnings | −$240K | −$3.9M |
| Net margin | -17.4% | — |
| Operating cash flow | −$223K | −$251K |
Questions
Which is bigger, Target Group or Nutra Pharma?
Target Group is the larger company: $1.4M of revenue in its latest quarter (Q2 2026) against $34K for Nutra Pharma (Q2 2026).
Is Target Group or Nutra Pharma growing faster?
Target Group is growing faster (+11% against -59% a year earlier).
More: Target Group earnings · how Target Group makes money · Nutra Pharma earnings · how Nutra Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 19, 2026). Fiscal quarters can end on different dates. Not investment advice.